Today on Pharmaceutical Processing
Alphabet’s Calico renews AbbVie partnership
Calico Life Sciences, an R&D biotech founded in 2013 as a Google subsidiary, is reaffirming its partnership with AbbVie (NYSE: ABBV) it initially formed in 2014. The latest agreement extends the collaboration from 2022 to 2025 while allotting $500 million in additional funding from both companies. The two companies are collaborating on three clinical stage…
Big pharma resists international corporate tax proposal
Pharma companies are resisting a tentative agreement between 130 countries to create a minimum corporate tax of 15%. The plan intends to combat tax inversion and other forms of tax avoidance. Some U.S. industries, including Big Tech, have backed the plan given its potential to simplify accounting — even if it increases their tax rate.…
Sponsored Content See More >
Noble expands its services for its clients into Human FactorsHuman Factors + (HF+) is a natural extension of Noble’s deep understanding of the patient experience relative to self-administering drug…
Regulatory See More >
Biden and Pelosi pursuing plans to cap drug prices
President Biden has instructed FDA to develop a plan to import prescription drugs from Canada while asking federal officials to create a “comprehensive plan” to cut drug prices within 45 days. Biden has also recommended that FTC block “pay for delay” agreements from pharma companies paying generic drug makers to hold off on introducing competitive…
Facility See More >
An inside look at Northern California’s growing biomanufacturing hub
Vacaville, Calif. is home to a burgeoning biotech hub. And there’s more to Vacaville’s biomanufacturing industry than Genentech’s presence there. “Genentech is just one of the biotech companies to open in Vacaville,” said Don Burrus, the city’s director of economic development services. “We’ve had biomanufacturers here for almost 30 years.” Genentech set up shop in…
Takeda and Capsida announce manufacturing plant investments in California
Using RVI to help prevent contamination and maintain the purity of pharmaceuticals
Biotech Agenus acquires 120 acres in biomanufacturing center in California
Gene therapy specialist Viralgen opens new facility in Spain’s Basque Country
Supply Chain See More >
Pfizer-BioNTech to provide U.S. with another 200M shots for kids, boosters
Pfizer (NYSE:PFE) and BioNTech (NSDQ:BNTX) announced today that the U.S. government has purchased another 200 million doses of their COVID-19 vaccine. Media outlets including CNN and the Financial Times cited a Biden administration official saying the additional doses are needed to vaccinate children under 12, pending FDA authorization, plus the potential need for additional booster…
Recalls See More >
Pfizer halts global shipments of Chantix over contamination worries
Pfizer (NYSE:PFE) has stopped international shipments of the smoking-cessation drug Chantix (varenicline) after concluding it had elevated levels of a potential carcinogen. The substance in question, nitrosamines, are organic compounds thought to cause cancer in various organisms. “We believe the benefits of Chantix/Champix outweigh the very low potential risks, if any, posed by nitrosamine exposure…
